modelP01BX02_1

Extends from Pharmacokinetic.Models.PK_3C_enteral.

Information

name:ArterolaneAndPiperaquine_1
ATC code:P01BX02_1
route:oral
compartments:3
dosage:750mg
volume of distribution:880L
clearance:5L/h
other parameters in model implementation

Arterolane and piperaquine is a fixed-dose combination antimalarial, currently used for the treatment of malaria, particularly in South Asia.

Pharmacokinetics

Pharmacokinetic parameters for piperaquine in healthy adult volunteers after oral administration of 750 mg piperaquine phosphate plus 150 mg arterolane maleate.

References

  1. Valecha, N, et al., & Anvikar, AR (2016). Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study. Malaria journal 15 42–None. DOI:10.1186/s12936-016-1084-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/26818020

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.VolumeVdp2 (from PK_3C)Vdp2PerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdp2PerKg (from PK_3C)0.9Volume of distribution peripheral 2 (l/kg)
Pharmacolibrary.Types.VolumeFlowRatek13 (from PK_3C)1intercompartmental 1-3 clearance (l/min)
Pharmacolibrary.Types.VolumeFlowRatek31 (from PK_3C)1intercompartmental 3-1 clearance (l/min)
Pharmacolibrary.Types.TransferRateka (from PK_3C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_3C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)
Interfaces.ConcentrationPort_bperihperal2Cport (from PK_3C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral2 (from PK_3C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral1 (from PK_3C)
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer1 (from PK_3C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)